TLX Annual CFI
-$16.92 M
-$5.12 M-43.34%
01 December 2023
Summary:
As of January 21, 2025, TLX annual cash flow from investing activities is -$16.92 million, with the most recent change of -$5.12 million (-43.34%) on December 1, 2023. During the last 3 years, it has fallen by -$16.17 million (-2144.54%). TLX annual CFI is now -1692060.00% below its all-time high of -$1000.00, reached on December 1, 2017.TLX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TLX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -43.3% | - | - |
| 3 y3 years | -2144.5% | - | - |
| 5 y5 years | -741.3% | - | - |
TLX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -726.6% | at low | ||||
| 5 y | 5-year | -5101.8% | at low | ||||
| alltime | all time | <-9999.0% | at low |
Telix Pharmaceuticals Limited Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$16.92 M(+43.3%) | - | - |
| Dec 2022 | -$11.81 M(+476.7%) | - | - |
| Dec 2021 | -$2.05 M(+171.5%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$753.90 K(+131.8%) | - | - |
| Dec 2019 | -$325.30 K(-83.8%) | - | - |
| Dec 2018 | -$2.01 M(>+9900.0%) | - | - |
| Dec 2017 | -$1000.00 | - | - |
FAQ
- What is Telix Pharmaceuticals Limited annual cash flow from investing activities?
- What is the all time high annual CFI for Telix Pharmaceuticals Limited?
- What is Telix Pharmaceuticals Limited annual CFI year-on-year change?
What is Telix Pharmaceuticals Limited annual cash flow from investing activities?
The current annual CFI of TLX is -$16.92 M
What is the all time high annual CFI for Telix Pharmaceuticals Limited?
Telix Pharmaceuticals Limited all-time high annual cash flow from investing activities is -$1000.00
What is Telix Pharmaceuticals Limited annual CFI year-on-year change?
Over the past year, TLX annual cash flow from investing activities has changed by -$5.12 M (-43.34%)